Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain.

PubWeight™: 2.42‹?› | Rank: Top 2%

🔗 View Article (PMID 10527748)

Published in J Magn Reson on November 01, 1999

Authors

J Pfeuffer1, I Tkác, S W Provencher, R Gruetter

Author Affiliations

1: Department of Radiology, University of Minnesota Medical School, Center for Magnetic Resonance Research, 2021 Sixth Street SE, Minneapolis, Minnesota 55455, USA.

Articles citing this

In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T. Magn Reson Med (2009) 2.27

Visual field map clusters in human cortex. Philos Trans R Soc Lond B Biol Sci (2005) 2.25

Effect of hypoglycemia on brain glycogen metabolism in vivo. J Neurosci Res (2003) 1.64

The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? Philos Trans R Soc Lond B Biol Sci (2006) 1.63

Multivariate Analysis in Metabolomics. Curr Metabolomics (2015) 1.61

Localized in vivo 13C NMR spectroscopy of the brain. NMR Biomed (2003) 1.55

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (2005) 1.47

Brain maturation in neonatal rodents is impeded by sevoflurane anesthesia. Anesthesiology (2015) 1.38

Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy. J Neurochem (2007) 1.38

Exchange rates of creatine kinase metabolites: feasibility of imaging creatine by chemical exchange saturation transfer MRI. NMR Biomed (2012) 1.34

In vivo 13C spectroscopy in the rat brain using hyperpolarized [1-(13)C]pyruvate and [2-(13)C]pyruvate. J Magn Reson (2010) 1.33

Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Mov Disord (2010) 1.30

Localized 1H NMR spectroscopy in different regions of human brain in vivo at 7 T: T2 relaxation times and concentrations of cerebral metabolites. NMR Biomed (2011) 1.29

Methodology of H NMR Spectroscopy of the Human Brain at Very High Magnetic Fields. Appl Magn Reson (2005) 1.25

In vivo 1H NMR spectroscopy of the human brain at 9.4 T: initial results. J Magn Reson (2010) 1.12

Short-echo, single-shot, full-intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: validation in the cerebellum and brainstem. Magn Reson Med (2010) 1.10

Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers. Mol Cancer (2010) 1.10

Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized (1)H MRS study. NMR Biomed (2009) 1.08

Dynamic or inert metabolism? Turnover of N-acetyl aspartate and glutathione from D-[1-13C]glucose in the rat brain in vivo. J Neurochem (2004) 1.08

Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia. MAGMA (2005) 1.06

Ammonia toxicity to the brain. J Inherit Metab Dis (2012) 1.04

Numerical simulations of localized high field 1H MR spectroscopy. J Magn Reson (2008) 1.04

Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Top Magn Reson Imaging (2008) 1.03

The application of NMR-based metabonomics in neurological disorders. NeuroRx (2006) 1.03

Quantification of high-resolution (1)H NMR spectra from rat brain extracts. Anal Chem (2010) 1.02

Quantitative proton spectroscopic imaging of the neurochemical profile in rat brain with microliter resolution at ultra-short echo times. Magn Reson Med (2008) 1.01

Semi-parametric time-domain quantification of HR-MAS data from prostate tissue. NMR Biomed (2010) 1.00

Sensitivity and source of amine-proton exchange and amide-proton transfer magnetic resonance imaging in cerebral ischemia. Magn Reson Med (2013) 0.99

Disturbed energy metabolism and muscular dystrophy caused by pure creatine deficiency are reversible by creatine intake. J Physiol (2012) 0.98

Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals. NeuroRx (2005) 0.97

In vivo neurochemical profiling of rat brain by 1H-[13C] NMR spectroscopy: cerebral energetics and glutamatergic/GABAergic neurotransmission. J Neurochem (2009) 0.96

Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Cerebellum (2011) 0.95

Noninvasive quantification of human brain ascorbate concentration using 1H NMR spectroscopy at 7 T. NMR Biomed (2010) 0.95

Low-power adiabatic sequences for in vivo localized two-dimensional chemical shift correlated MR spectroscopy. Magn Reson Med (2010) 0.93

In vivo characterization of several rodent glioma models by 1H MRS. NMR Biomed (2011) 0.92

In vivo proton MRS to quantify anesthetic effects of pentobarbital on cerebral metabolism and brain activity in rat. Magn Reson Med (2009) 0.92

Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection. J Neuroimmune Pharmacol (2013) 0.90

High-field proton magnetic resonance spectroscopy reveals metabolic effects of normal brain aging. Neurobiol Aging (2014) 0.90

Altered neurochemical profile after traumatic brain injury: (1)H-MRS biomarkers of pathological mechanisms. J Cereb Blood Flow Metab (2012) 0.89

Measurement of transverse relaxation times of J-coupled metabolites in the human visual cortex at 4 T. Magn Reson Med (2011) 0.87

Noninvasive quantification of T2 and concentrations of ascorbate and glutathione in the human brain from the same double-edited spectra. NMR Biomed (2010) 0.87

Sepsis-associated encephalopathy: a magnetic resonance imaging and spectroscopy study. J Cereb Blood Flow Metab (2009) 0.87

In vivo monitoring of adult neurogenesis in health and disease. Front Neurosci (2011) 0.87

Non-invasive quantification of brain glycogen absolute concentration. J Neurochem (2008) 0.87

In vivo high-resolution localized (1) H MR spectroscopy in the awake rat brain at 7 T. Magn Reson Med (2012) 0.87

Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis. Radiology (2010) 0.86

Hippocampus specific iron deficiency alters competition and cooperation between developing memory systems. J Neurodev Disord (2010) 0.86

High-resolution low-field molecular magnetic resonance imaging of hyperpolarized liquids. Anal Chem (2014) 0.86

Faster metabolite (1)H transverse relaxation in the elder human brain. PLoS One (2013) 0.85

Echo time optimization for J-difference editing of glutathione at 3T. Magn Reson Med (2016) 0.85

Comparison of brain gray and white matter macromolecule resonances at 3 and 7 Tesla. Magn Reson Med (2014) 0.85

Correlation chemical shift imaging with low-power adiabatic pulses and constant-density spiral trajectories. NMR Biomed (2011) 0.85

Postnatal morphine administration alters hippocampal development in rats. J Neurosci Res (2011) 0.85

Measurement of regional variation of GABA in the human brain by optimized point-resolved spectroscopy at 7 T in vivo. NMR Biomed (2014) 0.85

DYNAmic Multi-coIl TEchnique (DYNAMITE) shimming of the rat brain at 11.7 T. NMR Biomed (2014) 0.85

Quantification of high-resolution ¹H-[¹³C] NMR spectra from rat brain extracts. Anal Chem (2014) 0.84

Glutamate imaging (GluCEST) lateralizes epileptic foci in nonlesional temporal lobe epilepsy. Sci Transl Med (2015) 0.83

Magnetic resonance spectroscopy for evaluation of liposome-encapsulated hemoglobin as a resuscitation fluid. Artif Cells Blood Substit Immobil Biotechnol (2010) 0.83

Quantitative in vivo 1H spectroscopic imaging of metabolites in the early postnatal mouse brain at 17.6 T. MAGMA (2008) 0.82

Cerebral glutamine metabolism under hyperammonemia determined in vivo by localized (1)H and (15)N NMR spectroscopy. J Cereb Blood Flow Metab (2011) 0.82

Metabolic profiling of dividing cells in live rodent brain by proton magnetic resonance spectroscopy (1HMRS) and LCModel analysis. PLoS One (2014) 0.82

Multislice ¹H MRSI of the human brain at 7 T using dynamic B₀ and B₁ shimming. Magn Reson Med (2011) 0.81

B0 magnetic field homogeneity and shimming for in vivo magnetic resonance spectroscopy. Anal Biochem (2016) 0.79

Neuropharmacological and neurobiological relevance of in vivo ¹H-MRS of GABA and glutamate for preclinical drug discovery in mental disorders. Neuropsychopharmacology (2014) 0.79

Delayed hippocampal effects from a single exposure of prepubertal guinea pigs to sub-lethal dose of chlorpyrifos: a magnetic resonance imaging and spectroscopy study. Neurotoxicology (2013) 0.79

Challenges of using MR spectroscopy to detect neural progenitor cells in vivo. AJNR Am J Neuroradiol (2009) 0.79

Animal models and high field imaging and spectroscopy. Dialogues Clin Neurosci (2013) 0.79

Effect of carr-purcell refocusing pulse trains on transverse relaxation times of metabolites in rat brain at 9.4 Tesla. Magn Reson Med (2014) 0.79

Region-specific changes in ascorbate concentration during rat brain development quantified by in vivo (1)H NMR spectroscopy. NMR Biomed (2010) 0.78

Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders. Bioanalysis (2012) 0.78

Copper deficiency alters the neurochemical profile of developing rat brain. Nutr Neurosci (2009) 0.78

On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModel. PLoS One (2016) 0.78

Metabolism changes during aging in the hippocampus and striatum of glud1 (glutamate dehydrogenase 1) transgenic mice. Neurochem Res (2014) 0.78

A high fat diet alters metabolic and bioenergetic function in the brain: A magnetic resonance spectroscopy study. Neurochem Int (2016) 0.77

Probing astrocyte metabolism in vivo: proton magnetic resonance spectroscopy in the injured and aging brain. Front Aging Neurosci (2015) 0.77

31P magnetic resonance spectroscopy study of the human visual cortex during stimulation in mild hypoxic hypoxia. Exp Brain Res (2008) 0.77

Treatment effects in a transgenic mouse model of Alzheimer's disease: a magnetic resonance spectroscopy study after passive immunization. Neuroscience (2013) 0.77

PRESS-based proton single-voxel spectroscopy and spectroscopic imaging with very short echo times using asymmetric RF pulses. MAGMA (2003) 0.77

Longitudinal 1H MRS of rat forebrain from infancy to adulthood reveals adolescence as a distinctive phase of neurometabolite development. NMR Biomed (2013) 0.77

Quantification of in vivo ³¹P NMR brain spectra using LCModel. NMR Biomed (2015) 0.77

Neurochemical Changes Associated with Stress-Induced Sleep Disturbance in Rats: In Vivo and In Vitro Measurements. PLoS One (2016) 0.76

Differential Effects of Intrauterine Growth Restriction on the Regional Neurochemical Profile of the Developing Rat Brain. Neurochem Res (2015) 0.75

Brain metabolic pattern analysis using a magnetic resonance spectra classification software in experimental stroke. BMC Neurosci (2017) 0.75

Dynamic correlations between hemodynamic, metabolic, and neuronal responses to acute whole-brain ischemia. NMR Biomed (2015) 0.75

The use of magnetic resonance spectroscopy as a tool for the measurement of bi-hemispheric transcranial electric stimulation effects on primary motor cortex metabolism. J Vis Exp (2014) 0.75

Molecular Imaging Using Endogenous Cellular Proteins. Bo Pu Xue Za Zhi (2013) 0.75

Simultaneous measurement of glucose blood-brain transport constants and metabolic rate in rat brain using in-vivo 1H MRS. J Cereb Blood Flow Metab (2012) 0.75

Quantitative in vivo neurochemical profiling in humans: where are we now? Int J Epidemiol (2016) 0.75

In Vivo Detection of Perinatal Brain Metabolite Changes in a Rabbit Model of Intrauterine Growth Restriction (IUGR). PLoS One (2015) 0.75

NMR Based Cerebrum Metabonomic Analysis Reveals Simultaneous Interconnected Changes during Chick Embryo Incubation. PLoS One (2015) 0.75

In vivo 1H magnetic resonance spectroscopy of rat brain after valproate administration. Neuroradiology (2004) 0.75

Temperature dependence of (1)H NMR chemical shifts and its influence on estimated metabolite concentrations. MAGMA (2017) 0.75

Quantification of glutathione in the human brain by MR spectroscopy at 3 Tesla: Comparison of PRESS and MEGA-PRESS. Magn Reson Med (2016) 0.75

Everyman's prostate phantom: kiwi-fruit substitute for human prostates at magnetic resonance imaging, diffusion-weighted imaging and magnetic resonance spectroscopy. Eur Radiol (2017) 0.75

Decreased Glutamatergic Activity in the Frontal Cortex of Single Prolonged Stress Model: In vivo and Ex Vivo Proton MR Spectroscopy. Neurochem Res (2017) 0.75

Articles by these authors

Estimation of globular protein secondary structure from circular dichroism. Biochemistry (1981) 9.14

Simultaneous in vivo spectral editing and water suppression. NMR Biomed (1998) 5.09

In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med (1999) 4.26

A Fourier method for the analysis of exponential decay curves. Biophys J (1976) 3.83

Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med (2000) 3.13

Envelope structure of Semliki Forest virus reconstructed from cryo-electron micrographs. Nature (1986) 2.35

In vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med (2001) 2.12

Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab (1995) 1.98

A half-volume coil for efficient proton decoupling in humans at 4 tesla. J Magn Reson (1997) 1.84

Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Neurology (2005) 1.73

Echo-planar magnetic resonance imaging studies of frontal cortex activation during word generation in humans. Proc Natl Acad Sci U S A (1993) 1.60

In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia. J Cereb Blood Flow Metab (2001) 1.52

The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes (2001) 1.40

[Relationship of the CDKAL1 and KCNQ1 gene polymorphisms to the age at diagnosis of type 2 diabetes in the Slovakian population]. Vnitr Lek (2011) 1.39

Numerical solution of linear integral equations of the first kind. Calculation of molecular weight distributions from sedimentation equilibrium data. J Chem Phys (1967) 1.38

Methodology of H NMR Spectroscopy of the Human Brain at Very High Magnetic Fields. Appl Magn Reson (2005) 1.25

Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS. Magn Reson Med (2003) 1.19

Temporal and spatial analysis of fields generated by eddy currents in superconducting magnets: optimization of corrections and quantitative characterization of magnet/gradient systems. Magn Reson Med (1991) 1.19

Extracellular-intracellular distribution of glucose and lactate in the rat brain assessed noninvasively by diffusion-weighted 1H nuclear magnetic resonance spectroscopy in vivo. J Cereb Blood Flow Metab (2000) 1.18

Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging (1998) 1.18

Noninvasive measurements of [1-(13)C]glycogen concentrations and metabolism in rat brain in vivo. J Neurochem (1999) 1.14

Water diffusion in rat brain in vivo as detected at very large b values is multicompartmental. MAGMA (1999) 1.12

Magnetic resonance studies of brain function and neurochemistry. Annu Rev Biomed Eng (2000) 1.11

Pf1 filamentous bacterial virus. X-ray fibre diffraction analysis of two heavy-atom derivatives. J Mol Biol (1981) 1.10

Single-shot, three-dimensional "non-echo" localization method for in vivo NMR spectroscopy. Magn Reson Med (2000) 1.08

Study of tricarboxylic acid cycle flux changes in human visual cortex during hemifield visual stimulation using (1)H-[(13)C] MRS and fMRI. Magn Reson Med (2001) 1.08

Three-dimensional reconstruction from electron micrographs of disordered specimens. II. Implementation and results. Ultramicroscopy (1988) 1.06

Localized in vivo 1H NMR detection of neurotransmitter labeling in rat brain during infusion of [1-13C] D-glucose. Magn Reson Med (1999) 1.02

Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy. Cancer Res (1998) 0.99

Temporal SNR characteristics in segmented 3D-EPI at 7T. Magn Reson Med (2011) 0.97

Hyperpolarizing gases via dynamic nuclear polarization and sublimation. Phys Rev Lett (2010) 0.97

In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. Biophys Chem (1997) 0.95

Secondary structure of the pore-forming colicin A and its C-terminal fragment. Experimental fact and structure prediction. Eur J Biochem (1985) 0.95

Localized eddy current compensation using quantitative field mapping. J Magn Reson (1998) 0.94

Metabolic changes in quinolinic acid-lesioned rat striatum detected non-invasively by in vivo (1)H NMR spectroscopy. J Neurosci Res (2001) 0.94

Conformational analysis of galanin using end to end distance distribution observed by Förster resonance energy transfer. Eur Biophys J (1997) 0.89

Identification of a high concentration of scyllo-inositol in the brain of a healthy human subject using 1H- and 13C-NMR. Magn Reson Med (1998) 0.87

Direct analysis of continuous relaxation spectra. J Biochem Biophys Methods (1979) 0.85

Diffusion-weighted spectroscopy: a novel approach to determine macromolecule resonances in short-echo time 1H-MRS. Magn Reson Med (2010) 0.85

Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome. Physiol Res (2005) 0.83

Whole-brain glutamate metabolism evaluated by steady-state kinetics using a double-isotope procedure: effects of gabapentin. J Neurochem (2004) 0.83

Metabolic changes in rat brain after prolonged ethanol consumption measured by 1H and 31P MRS experiments. Cell Mol Neurobiol (2000) 0.81

In vivo observation of lactate methyl proton magnetization transfer in rat C6 glioma. Magn Reson Med (1999) 0.81

Detecting natural abundance carbon signal of NAA metabolite within 12-cm3 localized volume of human brain using 1H-[13C] NMR spectroscopy. Magn Reson Med (1998) 0.81

Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog. Liver Transpl Surg (1998) 0.80

Carotid intima-media thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus. Wien Klin Wochenschr (2000) 0.80

The secondary structure of salt-extracted ribosomal proteins from Escherichia coli as studied by circular dichroic spectroscopy. Biochim Biophys Acta (1986) 0.79

Motion artifacts reduction in DWI using navigator echoes: a robust and simple correction scheme. MAGMA (1998) 0.78

Stopped-flow solution scattering using synchrotron radiation: apparatus, data collection and data analysis. J Biochem Biophys Methods (1983) 0.78

Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients. Physiol Res (2005) 0.78

Analysis of the components present in kinetics (or titration) curves. J Biochem Biophys Methods (1983) 0.77

Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes. Atherosclerosis (1998) 0.77

An in vivo ultrahigh field 14.1 T (1) H-MRS study on 6-OHDA and α-synuclein-based rat models of Parkinson's disease: GABA as an early disease marker. NMR Biomed (2012) 0.77

Absolute metabolite quantification by in vivo NMR spectroscopy: III. Multicentre 1H MRS of the human brain addressed by one and the same data-analysis protocol. Magn Reson Imaging (1998) 0.77

Variations in the in vivo P-31 MR spectra of the developing human brain during postnatal life. Work in progress. Radiology (1989) 0.76

Synchronization device for electrocardiography-gated echo-planar imaging. Radiology (1995) 0.76

[Hypercoagulation states]. Vnitr Lek (1993) 0.76

Type IV renal tubular acidosis associated with Alport's syndrome. Postgrad Med J (1993) 0.75

[Echocardiographic findings in patients on a long-term dialysis regimen]. Vnitr Lek (1988) 0.75

Cardiovascular risk factors as predictors of mortality in type II diabetic patients. Wien Klin Wochenschr (1999) 0.75

[The present status of treatment of unstable angina pectoris]. Vnitr Lek (1994) 0.75

[Infections of the diabetic foot--etiopathogenesis and possible preventive strategies]. Vnitr Lek (1998) 0.75

[Effect of bisoprolol on heart rate variability in patients with hyperthyroidism]. Vnitr Lek (2000) 0.75

[Pulmonary embolism as a rare complication of a contusion in the inguinal region]. Vnitr Lek (1992) 0.75

[Neurohumoral activity in liver cirrhosis]. Vnitr Lek (1995) 0.75

[Evans' syndrome]. Vnitr Lek (1988) 0.75

[Neuroendocrine changes in chronic heart failure]. Vnitr Lek (1993) 0.75

[Infection of the diabetic foot--appropriate antibiotics and therapeutic strategies]. Vnitr Lek (1998) 0.75

Spirometric alterations in patients with reduced renal function. Wien Klin Wochenschr (1993) 0.75

Brain glycogen: an insulin-sensitive carbohydrate store. Diabetes Nutr Metab (2002) 0.75

[Changes in lipoprotein metabolism in patients with diabetes mellitus and the effect on lipid profile in diabetics]. Vnitr Lek (1994) 0.75

New approach for quantitation of short echo time in vivo 1H MR spectra of brain using AMARES. NMR Biomed (1998) 0.75

Application of NMR spectroscopy in biochemical studies of tumor cells sensitive and resistant to anticancer drugs. Neoplasma (1998) 0.75

[Rapid control of acute hypertensive conditions by administration of sublingual nifedipine]. Vnitr Lek (1986) 0.75

[Relation of polymorphism of genes controlling endothelial function and blood pressure and the occurrence of vascular complications in type 2 diabetes]. Vnitr Lek (2002) 0.75

[ECG Holter monitoring in patients with chronic renal failure in a long-term dialysis program]. Vnitr Lek (1992) 0.75